
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 5.90 | 5.93 | 0.03 |
Shares | 90.50 | 90.50 | 0.00 |
Convertible | 0.03 | 0.03 | 0.00 |
Preferred | 3.01 | 3.01 | 0.00 |
Other | 0.55 | 0.55 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.37 | 19.18 |
Price to Book | 3.62 | 4.34 |
Price to Sales | 3.75 | 2.43 |
Price to Cash Flow | 12.07 | 16.74 |
Dividend Yield | - | 1.12 |
5 Years Earnings Growth | 8.96 | 12.19 |
Number of long holdings: 87
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Verona Pharma ADR | US9250501064 | 4.41 | 67.880 | +0.52% | |
Scholar Rock | US80706P1030 | 3.97 | 31.51 | -2.94% | |
Mirum Pharmaceuticals | US6047491013 | 3.73 | 45.15 | -0.92% | |
Insmed | US4576693075 | 3.60 | 66.47 | -1.88% | |
Guardant Health | US40131M1099 | 3.43 | 41.67 | +0.02% | |
Blueprint Medicines Corp | US09627Y1091 | 2.93 | 99.60 | -0.71% | |
Collegium Pharmaceutical | US19459J1043 | 2.85 | 29.82 | +0.88% | |
Celldex Therapeutics | US15117B2025 | 2.65 | 19.67 | -2.55% | |
Aura Biosciences Inc | - | 2.59 | - | - | |
Sarepta | US8036071004 | 2.56 | 37.11 | +2.03% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Eventide Gilead I | 1.9B | -5.10 | 1.52 | 8.07 | ||
Eventide Gilead N | 285.39M | -5.18 | 1.31 | 7.86 | ||
Eventide Gilead A | 280.6M | -5.18 | 1.27 | 7.81 | ||
Eventide Gilead C | 130.1M | -1.03 | -7.67 | 8.20 | ||
Eventide Healthcare & Life ScienceA | 90.3M | -10.36 | -7.32 | 7.17 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review